Nu Skin Enterprises Inc (NUS)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 48,268 59,664 65,745 74,766 110,847 103,707 189,375 223,224 233,992 302,370 311,214 283,912 257,564 223,546 219,210 235,338 267,426 231,178 241,961 250,523
Total assets US$ in thousands 1,806,460 1,793,090 1,893,780 1,824,640 1,820,970 1,763,170 1,900,900 1,892,250 1,906,480 1,974,410 2,049,980 1,950,100 1,957,080 1,816,710 1,794,490 1,746,320 1,769,010 1,736,900 1,791,100 1,755,100
Operating ROA 2.67% 3.33% 3.47% 4.10% 6.09% 5.88% 9.96% 11.80% 12.27% 15.31% 15.18% 14.56% 13.16% 12.30% 12.22% 13.48% 15.12% 13.31% 13.51% 14.27%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $48,268K ÷ $1,806,460K
= 2.67%

The operating return on assets (operating ROA) for Nu Skin Enterprises, Inc. has exhibited a declining trend over the past eight quarters. In Q1 2022, the operating ROA was at its highest point at 14.54%, but it has steadily decreased since then. As per the data provided, the operating ROA decreased to 3.77% in Q4 2023.

This downward trend indicates a potential decrease in the company's operating efficiency and/or profitability in generating earnings from its assets over time. It is essential for investors and stakeholders to closely monitor this metric as it reflects the company's ability to utilize its assets effectively to generate operating income.

Further analysis would be required to identify the specific factors contributing to the decline in operating ROA and to determine the strategies that Nu Skin Enterprises, Inc. could implement to improve its operating efficiency and profitability in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
Nu Skin Enterprises Inc
NUS
2.67%
Cardinal Health Inc
CAH
2.77%
Cencora Inc.
COR
3.91%
McKesson Corporation
MCK
5.80%